[HTML][HTML] Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal

S Ranjitkar, ML Schousboe, TT Thomsen, M Adhikari… - Malaria Journal, 2011 - Springer
Background Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in
treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have …

[HTML][HTML] Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola

V Foumane Ngane, J Allico Djaman, C Culeux, N Piette… - Malaria Journal, 2015 - Springer
Background The malaria situation has been worsening in Angola, partly due to armed
conflict until the recent past and drug-resistant Plasmodium falciparum. Malaria transmission …

[HTML][HTML] Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and …

TT Thomsen, DS Ishengoma… - The American journal …, 2011 - ncbi.nlm.nih.gov
Tanzania implemented artemether-lumefantrine (AL) as the first-line treatment for
uncomplicated malaria in November of 2006 because of resistance to sulfadoxine …

[HTML][HTML] How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review

S Moss, E Mańko, S Krishna, S Campino, TG Clark… - Malaria journal, 2022 - Springer
Abstract The World Health Organization (WHO) recommends surveillance of molecular
markers of resistance to anti-malarial drugs. This is particularly important in the case of mass …

[HTML][HTML] Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20 years (1999 to 2019)

P Berzosa, I Molina de la Fuente, TH Ta-Tang… - Malaria Journal, 2021 - Springer
Background Malaria is one of the deadliest diseases in the world, particularly in Africa. As
such, resistance to anti-malarial drugs is one of the most important problems in terms of …

[HTML][HTML] Molecular surveillance of Plasmodium falciparum drug resistance markers in clinical samples from Botswana

L Tawe, M Menegon, P Ramatlho… - The American Journal …, 2018 - ncbi.nlm.nih.gov
Drug-resistant Plasmodium falciparum is a major threat to global malaria control and
elimination efforts. In Botswana, a southern African country approaching malaria elimination …

In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance‐associated mutations of Plasmodium …

ID Ferreira, D Lopes, A Martinelli… - Tropical Medicine & …, 2007 - Wiley Online Library
Objective To evaluate the basal in vitro responses of Plasmodium falciparum isolates
collected in The Democratic Republic of São Tomé and Príncipe to artemether (ATH) …

In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity …

NW Lucchi, F Komino, SA Okoth… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Malaria control is hindered by the evolution and spread of resistance to antimalarials,
necessitating multiple changes to drug policies over time. A comprehensive antimalarial …

[HTML][HTML] Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project

T Thita, P Jadsri, J Thamkhantho, T Ruang-Areerate… - Malaria Journal, 2018 - Springer
Abstract Background In Thailand, artemisinin-based combination therapy (ACT) has been
used to treat uncomplicated falciparum malaria since 1995. Unfortunately, artemisinin …

[HTML][HTML] Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates

SV Dlamini, K Beshir, CJ Sutherland - Malaria journal, 2010 - Springer
Abstract Background The development of Plasmodium falciparum resistance to chloroquine
(CQ) has limited its use in many malaria endemic areas of the world. However, despite …